In recent years, there has been a growth in scientific interest in nutraceuticals, which are those nutrients in foods that have beneficial effects on health. Nutraceuticals can be extracted, used for food supplements, or added to foods. There has long been interest in the antiviral properties of nutraceuticals, which are especially topical in the context of the ongoing COVID-19 pandemic. Therefore, the purpose of this review is to evaluate the main nutraceuticals to which antiviral roles have been attributed (either by direct action on viruses or by modulating the immune system), with a focus on the pediatric population. Furthermore, the possible applications of these substances against SARS-CoV-2 will be considered.

Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature

Parisi G. F.;Carota G.;Castracani C. C.;Spampinato M.;Manti S.;Papale M.;Di Rosa M.;Barbagallo I.;Leonardi S.
2021-01-01

Abstract

In recent years, there has been a growth in scientific interest in nutraceuticals, which are those nutrients in foods that have beneficial effects on health. Nutraceuticals can be extracted, used for food supplements, or added to foods. There has long been interest in the antiviral properties of nutraceuticals, which are especially topical in the context of the ongoing COVID-19 pandemic. Therefore, the purpose of this review is to evaluate the main nutraceuticals to which antiviral roles have been attributed (either by direct action on viruses or by modulating the immune system), with a focus on the pediatric population. Furthermore, the possible applications of these substances against SARS-CoV-2 will be considered.
2021
Children
COVID-19
Hesperidin
Lactoferrin
Nutraceutical
Probiotics
Quercetin
Resveratrol
SARS-CoV2
Viral infections
Vita-min
Zinc
Antiviral Agents
COVID-19
Child
Humans
Probiotics
Randomized Controlled Trials as Topic
SARS-CoV-2
Virus Diseases
Dietary Supplements
File in questo prodotto:
File Dimensione Formato  
nutraceutici.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Dimensione 1.24 MB
Formato Adobe PDF
1.24 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/523791
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 22
social impact